Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

123
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
123
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K
Hazard Ratio01:12

Hazard Ratio

92
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
92
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Hazard Rate01:11

Hazard Rate

92
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing Risk Misinformation and Miscommunication: A Sheaf-Theoretic Perspective.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Necessary conditions for valid causal inference from observational data.

Critical reviews in toxicology·2026
Same author

Integrating Fragmented Risk Knowledge: Sheaf Theory for Risk Analysts.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Combining Diverse Expert Opinions in Risk Analysis Using Relative Causal Knowledge.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Improving the design of epidemiology studies that use biomonitoring for exposure assessment: a SciPinion panel recommendation.

BMC medical research methodology·2026
Same author

Living with risk, then and now: A dual review of Cam Grey's Living with Risk in the Late Roman World and of current AI-assisted book reviewing.

Risk analysis : an official publication of the Society for Risk Analysis·2025

Related Experiment Video

Updated: Jun 13, 2025

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K

Calculating preventable risk fractions for exposure-reducing interventions.

Louis Anthony Cox1

  • 1Cox Associates, Entanglement, University of Colorado, Denver, CO, USA.

Global Epidemiology
|June 11, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces new causal metrics like Preventable Risk Fraction (PRF) curves to quantify how much risk reduction is possible from lowering environmental and occupational exposures. These tools offer scientifically rigorous, individual-level predictions for better risk assessment and policy.

Keywords:
BenzeneCausal Bayesian networksCausal analysisEpidemiologyInterventional probability of causationPreventable risk fractionsRisk assessment

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 13, 2025

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Environmental Health
  • Epidemiology
  • Causal Inference

Background:

  • Traditional metrics like Population Attributable Fractions (PAFs) have limitations for interventional causal questions.
  • Misuse of association-based metrics can lead to inaccurate risk assessments.

Purpose of the Study:

  • To introduce novel causal metrics for quantifying preventable risk fractions from environmental and occupational exposures.
  • To provide tools for scenario-specific, individual-level risk reduction predictions based on mechanistic causality.

Main Methods:

  • Introduction of Interventional Probability of Causation (IPoC), Causal Assigned Shares (CAS), and Preventable Risk Fraction (PRF) curves.
  • Application of methods to case studies: benzene and AML, smoking and lung cancer, blood lead and mortality.
  • Utilizing Monte Carlo simulations for inter-individual variability and scenario analyses for practical thresholds.

Main Results:

  • PRF curves effectively quantify risk-reduction benefits from exposure reductions at individual and population levels.
  • Demonstrated ability to handle uncertainty and heterogeneity in exposure-risk relationships.
  • Identified thresholds where further exposure reductions yield diminishing returns.

Conclusions:

  • The proposed causal framework shifts focus from attribution to prevention of harm.
  • Offers a transparent, rigorous approach for evidence-based risk assessment, policy development, and legal decision-making.
  • Enables quantification of causally effective interventions and risk-reduction benefits.